SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001104659-10-064202
Filing Date
2010-12-23
Accepted
2010-12-23 16:02:42
Documents
9
Period of Report
2010-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q/A a10-22104_110qa.htm 10-Q/A 50271
2 EX-10.1 a10-22104_1ex10d1.htm EX-10.1 64797
3 EX-10.2 a10-22104_1ex10d2.htm EX-10.2 91463
4 EX-10.3 a10-22104_1ex10d3.htm EX-10.3 10963
5 EX-31.1 a10-22104_1ex31d1.htm EX-31.1 11443
6 EX-31.2 a10-22104_1ex31d2.htm EX-31.2 11779
7 EX-32.1 a10-22104_1ex32d1.htm EX-32.1 6224
8 EX-32.2 a10-22104_1ex32d2.htm EX-32.2 6233
9 GRAPHIC g221041kii001.jpg GRAPHIC 8308
  Complete submission text file 0001104659-10-064202.txt   266367
Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-15006 | Film No.: 101272380
SIC: 2835 In Vitro & In Vivo Diagnostic Substances